Synthesis and Characterization of Maillard Reaction Products of Salbutamol and Terbutaline with Lactose and Development and Validation of an LC Method for the Determination of Salbutamol and Terbutaline in the Presence of These Impurities by Asmaa A. El-Zaher et al.
1 AnAlyticAl chemistry insights 2014:9
Open Access: Full open access to 
this and thousands of other papers at 
http://www.la-press.com.
Analytical Chemistry 
Insights
Introduction
Salbutamol (SLB), (RS)-4-[2-(tert-butylamino)-1-hydroxyethyl]- 
2-(hydroxymethyl)phenol  (Fig.  1),  and  terbutaline  (TRB), 
(RS)-5-[2-(tert-butylamino)-1-hydroxyethyl]benzene-1,3-
diol  (Fig.  2),  are  two  well-known  β2-adrenergic  receptor   
agonists used for the relief of bronchospasm in conditions such 
as asthma and chronic obstructive pulmonary disease.1
The reaction between amino compounds and reducing 
sugars is known as Maillard reaction (MR), and the chemical 
pathways of the MR are very complicated. The majority of 
“small molecule” active pharmaceutical ingredient instability 
reactions occur via hydrolysis, oxidation, and MR.2 Drugs that 
are secondary amines, not just primary amines, are reported 
to undergo MR with lactose under pharmaceutically related 
conditions.
Hodge presented it as a multistage reaction series in 
which each stage depends on a number of controlling fac-
tors such as temperature, pH, and nature of reactants.3 High 
temperature and high pH support a quick completion of the 
reaction.  However,  degradation  products  formed  by  MR 
have also been observed under less extreme conditions in 
pharmaceutical products containing both lactose, an excipi-
ent commonly used in solid dosage formulations,4 and drug 
substances  containing  amino  groups,  such  as  fluoxetine 
hydrochloride,5 aminophylline, amlodipine, acyclovir,2 and 
baclofen.6
Formation  of  MR  impurities  was  also  reported  in 
memantine tablets,7 and they were simultaneously determined 
with memantine in tablets using LC with charged aerosol 
detector.8
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figure 1. A schematic diagram showing mr between lactose and slB by 
refluxing with triethylamine in dimethylacetamide and ethanol.
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figure 2. A schematic diagram showing mr between lactose and trB by 
refluxing with triethylamine in dimethylacetamide and ethanol.
Several analytical methods have been described for the 
determination of SLB in pharmaceutical and biological sam-
ples. These methods include spectrophotometry,9–12 LC,13,14 
LC–MS/MS,15  capillary  electrophoresis,16–18  and  TLC.19 
TRB has been analyzed by spectrophotometry,20,21 LC,22–25 
capillary electrophoresis,26 and HPTLC.27
Survey of many generic formulations of SLB and TRB 
revealed the presence of lactose as the most common excipi-
ent,  which  makes  the  formulation  less  stable  than  those 
including starch as diluent because of the possibility of MR 
between each of the two drugs, being secondary amines, and 
being lactose. Based on this knowledge, the aim of this work 
was to synthesize MR adducts of both SLB and TRB with 
lactose (SARP and TARP, respectively) and to elucidate their 
chemical  structures  by  different  spectroscopic  techniques. 
The method of Wirth et al.5 to prepare fluoxetine adduct was 
adapted to SLB and TRB. In addition, a sensitive, precise, and 
accurate LC method was to be developed and validated for the 
determination of these β2-adrenergic agonists in tablets, each 
spiked with its MR impurity. A schematic diagram showing 
the MR between lactose and SLB or TRB is presented in 
Figures 1 and 2. No reported method has described the sepa-
ration of the cited drugs from their adduct impurities, which 
is the aim of the present investigation.
experimental
Instrumentation.  The  HPLC  system  consisted  of 
Shimadzu LC-20AT Liquid Chromatograph (Japan) using a 
Symmetry Waters C18 column (150 mm × 4.6 mm, 5 µm). The 
system was equipped with a UV–visible detector (SPD-20A, 
Japan) and an autosampler (SIL-20A, Shimadzu, Japan). An 
Elma S100 ultrasonic processor model KBK 4200 (Germany) 
was used for the degassing of the mobile phases. Mass spec-
tra were performed on Shimadzu GCMS-QP1000EX mass 
spectrophotometer (Kyoto, Japan).
Materials  and  reagents.  Pharmaceutical  grade  SLB, 
lactose monohydrate, and ventolin tablets, nominally contain-
ing SLB equivalent to 2 mg of SLB and 139.8 mg of lactose 
monohydrate per tablet, were supplied by GlaxoSmithKline 
Company  (Cairo,  Egypt).  Pharmaceutical  grade  TRB  and Determination of salbutamol and terbutaline in presence of maillard products
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Aironyl tablets, nominally containing 2.5 mg of TRB and 
97.1 mg of lactose monohydrate per tablet, were supplied by 
SEDICO Pharmaceutical Company (6 October City, Egypt). 
Acetonitrile (HiPerSolv) was purchased from Fisher Scientific 
(Loughborough, Leicestershire, UK). Orthophosphoric acid 
(85%) was obtained from VWR Chemicals (Pool, England).   
Bi-distilled water was produced in-house (Aquatron Water Still, 
A4000D, UK). Membrane filters (0.45 µm) from Teknokroma 
(Barcelona, Spain) were used. N,N-Dimethylacetamide and 
triethylamine were purchased from Loba Chemie Pvt. Ltd. 
(Bombay, India). All other chemicals and reagents used were 
of analytical grade unless indicated otherwise.
Preparation  of  lactose-salbutamol  (sArP)  and 
lactose-terbutaline  (tArP)  Amadori  rearrangement 
products. In a 100 mL round-bottom flask, 3 g of lactose 
monohydrate (8.325 mmol) and 1 g of SLB (4.176 mmol) 
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or 1 g of TRB (3.64 mmol) were dissolved in 50 mL of 
ethanol. In all, 24 mL of dimethylacetamide and 0.6 mL 
of triethylamine (4.305 mmol) were added. The mixture 
was refluxed stirring for 48 hours. The reaction mixture 
was cooled and filtered, and the residue was washed with 
25 mL of ethanol. The filtrate was evaporated under vacuo 
to a thick solution. A total of 30 mL of ethyl acetate, 30 mL 
of  20%  aqueous  sodium  chloride,  and  10  mL  of  ether 
were added. The pH was adjusted to 11 with 50% sodium 
hydroxide. The layers were separated, and the bottom layer 
was discarded and the upper layer was set aside. To the 
middle layer, 30 mL of ethyl acetate and 10 mL of ether 
were added. The layers were separated, and the combined 
organic layers were evaporated under vacuo, to which were 
added 20 mL of 20% aqueous sodium chloride, 40 mL of 
water, and 60 mL of chloroform. The pH was adjusted to 
1.5 with concentrated HCl. The layers were separated, and 
to the aqueous layer were added 6 g of NaCl, 50 mL of ethyl 
acetate, and 10 mL of ether. The pH was adjusted to 10.6 
with 50% NaOH, and the layers were separated. The ethyl 
acetate layer was evaporated in vacuum to give a residue of 
1.8 g of SARP or 2.3 g of TARP.
chromatographic conditions. Chromatographic  sepa-
ration  was  achieved  on  a  Symmetry  Waters  C18  column 
(150 mm × 4.6 mm, 5 µm). Isocratic elution using a mobile 
phase consisting of 0.5% aqueous phosphoric acid and ace-
tonitrile (90:10, v/v) at a flow rate of 0.7 mL minute−1 was 
applied.  Quantitation  was  achieved  using  UV  detection  at 
230  nm.  The  acidic  aqueous  solution  was  filtered  through 
0.45 µm membrane filter and degassed for 30 minutes in an 
ultrasonic bath before use. Analyses were performed at ambi-
ent temperature, and the injection volume was 25 µL.
standard solutions. Standard stock solutions of each drug 
(1 mg mL−1) were prepared by dissolving 100 mg of the drug 
in methanol in a 100 mL volumetric flask and then completed 
to volume with methanol. Standard stock solutions, SARP 
and TARP impurities (1 mg mL−1), were prepared by dissolv-
ing 100 mg of the prepared adduct in methanol in a 100 mL 
volumetric flask and then completed to volume with methanol. 
Then required concentrations were prepared by serial dilutions 
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figure 5. hPlc chromatogram of slB sulfate (10 µg ml−1) (a) and sArP 
(3 µg ml−1) (b).
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figure 6. hPlc chromatogram of trB sulfate (10 µg ml−1) (a) and tArP 
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with methanol of these stock solutions. Laboratory-prepared 
mixtures were prepared by spiking standard solutions of SLB 
and TRB with their lactose-adducts prepared in Section 2.3.
sample preparations. A total of 20 tablets of each drug were 
weighed. An accurately weighed amount of the finely powdered 
ventolin tablets equivalent to 24 mg of SLB base (28.8 mg SLB) 
and Aironyl tablets equivalent to 20 mg of TRB were separately 
made up to 100 mL with methanol. The solutions were sonicated 
for five minutes to dissolve and filtered followed by serial dilu-
tion to the required concentrations for each experiment.
results and discussion
Preparation and characterization of sArP and tArP. 
The MR between SLB and TRB with lactose to produce the 
SARP or TARP, respectively, is shown in Figures 1 and 2. As 
reviewed in literature, preparation of Amadori rearrangement 
product of fluoxetine, which is a secondary amine drug, can be 
achieved by reaction of lactose with fluoxetine hydrochloride 
in N,N-dimethylacetamide and ethanol as solvent with trieth-
ylamine as the base.5 Following the same published procedure, 
SARP or TARP was obtained by reaction of lactose with SLB 
Table 1. system suitability tests for lc method for the determination 
of slB and trB in the presence of their mr impurities.
ITeM SLb TRb
n 2829 2827
t 1.03 1.05
%RSD of six injections of
Peak area 0.78 0.93
retention time 0.11 0.31
 
Table 2. results obtained by lc method for the determination of slB and trB in the presence of their mr impurities.
ITeM SLb TRb
retention time (minute) 2.46 3.08
Wavelength of detection (nm) 230 230
linearity
range of linearity (µg ml−1) 0.20–60 0.5–80
regression equation
− µ =− 1  gmL Area   233051 366156 C gmL Area    C − µ =− 1 244255 526308
Regression coefficient (r2) 0.9981 0.9973
lOD (ng ml−1) 33.71 70.96
lOQ (ng ml−1) 112.36 236.50
Precision
intra-day %rsD 0.33–0.41 0.18–1.60
inter-day %rsD 0.85–1.64 0.28–1.36
Drug in dosage form 102.83 ± 0.34 99.33 ± 0.53
Accuracy
Drug in bulk 99.88 ± 0.48 100.24 ± 0.75
abbreviations: lOD: limit of detection; lOQ: limit of quantitation.
or TRB. It was purified by extractions. Mass spectrometry 
confirmed the chemical structures and indicated the molecu-
lar weight to be 563 (M + 2H+, m/z 565) for SARP (Fig. 3) 
and 549 (M + H+, m/z 550) for TARP (Fig. 4).
Lc  method  development.  During  the  optimization 
cycle,  various  reversed-phase  columns,  isocratic  mobile 
phase systems, and pH values of the buffer were attempted. 
To detect each of SLB and TRB and their MR impurity 
with sufficient peak intensity, a wavelength of 230 nm was 
selected. It was found that at least 90% of aqueous phase was 
needed to elute all peaks within 10 minutes because of rela-
tively high polarity of the drugs and their lactose-adducts. 
Isocratic elution based on a mobile phase consisting of 0.5% 
aqueous phosphoric acid and acetonitrile (90:10, v/v) at a 
flow rate of 0.7 mL minute−1 was applied. The retention times 
were 2.46 and 3.66 minutes for SLB and SARP, respectively, 
as shown in Figure 5, and the retention times were 3.08 and 
4.52 minutes for TRB and TARP, respectively, as shown in 
Figure 6.
system suitability tests. System suitability tests are an 
integral part of liquid chromatographic methods in the course 
of optimizing the conditions of the proposed method.28%RSD 
of peak area for six injections of a solution of 30 or 40 µg mL−1 
(100%  concentration)  for  SLB  or  TRB,  respectively,  was 
used  to  test  repeatability,  and%RSD  of  retention  time  to 
test retention time reproducibility. The results of these tests 
for the proposed method are listed in Table 1. Drugs under 
investigation were well resolved from their MR impurities as 
shown in Figures 5 and 6. Resolution factors were found to 
be 2.404 between SLB and SARP and 2.403 between TRB 
and TARP.
Method validation. Linearity. In this study, eight con-
centrations were chosen for each drug. Each concentration was El-Zaher et al
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precision were all found to be less than 2%. The results are 
displayed in Tables 1 and 2.
Specificity. Good resolution and absence of interference 
from any of the MR impurities are shown in Figures 5 and 6. 
Also, the chromatograms of the pharmaceutical formulation 
samples were checked for the appearance of any extra peaks. 
No chromatographic interference from any of the excipients 
was found at the retention times of each of the examined 
drugs after extraction of the active ingredient (Figs. 7 and 8). 
In addition, the chromatograms of SLB and TRB in the sam-
ple solution were found to be identical to the chromatogram 
obtained by the standard solutions.
Limit of detection (LOD) and limit of quantitation (LOQ). 
Limit of detection that represents the concentration of analyte 
at S/N ratio of 3 and limit of quantification at which S/N ratio 
is 10 were determined experimentally for the proposed meth-
ods, and the results are given in Table 2.
Robustness.  Robustness  was  performed  by  deliberately 
changing the chromatographic conditions. The flow rate of 
repeated three times. Good linearity of the calibration curves 
was verified by the high correlation coefficient (Table 2).
Accuracy. Accuracy of the results was calculated by per-
centage recovery of five different concentrations of SLB and 
TRB standard solutions spiked with different quantities of 
SARP and TARP impurities in standard solutions (3–5 and 
3–7 µg mL−1), respectively (10–30%) (w/w). Triplicate sample 
preparations were made at each concentration level. The results 
obtained including the mean of the recoveries and standard 
deviation are displayed in Table 2 indicating good accuracy of 
the proposed method.
Precision.  For  SLB  and  TRB,  repeatability  of  the 
method was assessed by analyzing a standard solution con-
taining 30 and 40 µg mL−1, respectively (n = 6). In addi-
tion, intra-day and inter-day precision (using three different 
concentrations  in  triplicates  for  three  consecutive  days) 
was also carried out. The three concentrations applied are 
(24–30–36 µg mL−1) for SLB and (32–40–48 µg mL–1) for 
TRB,  representing  80–100–120%,  respectively.  The  val-
ues of%RSD of repeatability and intra-day and inter-day 
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figure 8. hPlc chromatogram of Aironyl tablets containing 10 µg ml−1 
trB sulfate.
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the mobile phase was changed from 0.7 to 0.6 and 0.8 mL 
minute−1. The organic strength was varied by ±2%. It was 
found that these variations did not affect the chromatographic 
resolution significantly when the proposed LC method was 
applied for the determination of SLB and TRB, each in the 
presence of its Maillard impurity.
conclusion
The MR products of SLB and TRB with lactose were synthe-
sized, and their chemical structures were elucidated. The pro-
posed LC method has the advantages of simplicity, precision, 
accuracy, and convenience for the separation and quantitation 
of SLB and TRB. In addition, it is suitable for the simulta-
neous determination of their binary mixtures with their MR 
impurities. Hence, the proposed LC method can be used for 
the quality control of the cited drugs in ordinary laboratories.
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